Short Interest in Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) Declines By 43.1%

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF - Get Free Report) was the recipient of a significant decline in short interest in February. As of February 15th, there was short interest totalling 469,800 shares, a decline of 43.1% from the January 31st total of 825,200 shares. Based on an average daily volume of 100 shares, the short-interest ratio is presently 4,698.0 days.

Recordati Industria Chimica e Farmaceutica Price Performance

Shares of OTCMKTS RCDTF remained flat at $55.54 during trading on Wednesday. The company has a market cap of $11.46 billion, a P/E ratio of 27.77 and a beta of 0.30. The company's 50-day simple moving average is $55.34 and its 200 day simple moving average is $53.32. Recordati Industria Chimica e Farmaceutica has a 1 year low of $52.25 and a 1 year high of $52.25.

Recordati Industria Chimica e Farmaceutica Company Profile

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.